GlassScriptPhysician profile
Michael W Cammarata
NPI 1235390535
$13,135.39
in general payments reported to CMS, 2019-2025
45 companies · $3,057 in 2025
The $3,057 reported for 2025 was more than what 75% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,760 · 2020: $1,049 · 2021: $1,501 · 2022: $2,228 · 2023: $2,154 · 2024: $1,386 · 2025: $3,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,362 · Travel and Lodging: $1,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,362.22 |
| Travel and Lodging | $1,234.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,879.18 | 2019-2025 | Triclip, Aveir, Jot Dx |
| Novartis Pharmaceuticals Corporation | $1,264.97 | 2019-2025 | |
| Amgen INC. | $991.03 | 2019-2025 | Repatha |
| Janssen Pharmaceuticals, INC | $948.49 | 2019-2023 | Xarelto |
| Medtronic, INC. | $947.99 | 2021-2025 | Corevalve Evolut R, Linq II, Aurora Ev-Icd Mri Surescan |
| Pfizer INC. | $779.04 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $414.77 | 2019-2025 | Wainua, Farxiga |
| Amarin Pharma, INC. | $352.53 | 2019-2023 | |
| Boston Scientific Corporation | $327.49 | 2019-2025 | Watchman Flx, Watchman, Farapulse |
| Boehringer Ingelheim Pharmaceuticals, INC. | $312.12 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $283.93 | 2020-2023 | Lifevest |
| Sanofi-Aventis U.S. LLC | $251.58 | 2019-2024 | |
| Cardiva Medical, INC. | $242.64 | 2021-2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade 5f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| E.R. Squibb & Sons, L.L.C. | $225.89 | 2021-2024 | Camzyos |
| Heartflow, INC. | $199.70 | 2022-2025 | Ffrct |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $190.10 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $181.09 | 2019-2024 | Livalo |
| Zoll Circulation INC | $180.50 | 2021 | |
| Philips North America LLC | $175.33 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und, (Cm9) Amb Mon & Diag Und |
| Edwards Lifesciences Corporation | $134.56 | 2023-2024 | Pascal, Evoque, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Merck Sharp & Dohme LLC | $88.12 | 2021-2025 | Verquvo, Capvaxive |
| Cvrx, INC. | $82.83 | 2023-2025 | Barostim Neo System |
| Kiniksa Pharmaceuticals International, Plc | $72.41 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $64.76 | 2025 | Assure Wcd |
| Agepha Pharma Fz LLC | $64.33 | 2024-2025 | Lodoco |
| Chiesi USA, INC. | $57.66 | 2019-2025 | Kengreal |
| Irhythm Technologies, INC. | $49.21 | 2023 | Zio Xt Patch |
| Bayer Healthcare Pharmaceuticals INC. | $40.77 | 2022-2024 | |
| Alnylam Pharmaceuticals INC. | $34.66 | 2025 | Onpattro |
| Arbor Pharmaceuticals, INC. | $33.00 | 2019-2020 | |
| Novo Nordisk INC | $31.65 | 2021-2024 | Wegovy |
| Ge Healthcare | $26.82 | 2022 | |
| Cleerly, INC. | $26.76 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Atricure, INC. | $21.84 | 2021 | |
| Akcea Therapeutics, INC. | $20.86 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $20.74 | 2022 | |
| Esperion Therapeutics, INC. | $19.41 | 2025 | Nexletol |
| Siemens Medical Solutions USA, INC. | $17.89 | 2020 | |
| Medtronic Vascular, INC. | $17.58 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $16.57 | 2025 | Evkeeza, Praluent |
| Astellas Pharma US INC | $16.37 | 2019 | |
| Bardy Diagnostics, INC. | $15.00 | 2022 | |
| Medicure Pharma INC. | $13.22 | 2025 | Zypitamag |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cammarata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.